Hypothesis: combined inhibition of complement and CD14 as treatment regimen to attenuate the inflammatory response. (Q37331701)
Jump to navigation
Jump to search
scientific article published on January 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Hypothesis: combined inhibition of complement and CD14 as treatment regimen to attenuate the inflammatory response. |
scientific article published on January 2008 |
Statements
Hypothesis: combined inhibition of complement and CD14 as treatment regimen to attenuate the inflammatory response (English)
Terje Espevik
2 references
Tom Eirik Mollnes
2 references
Dorte Christiansen
Ole-Lars Brekke